update desk

Israel shuts down last COVID ward

The Israeli Health Ministry recorded 12,487 Israeli deaths from the coronavirus since March 20, 2020.

A nurse cares for a baby at Hadassah Medical Center-Ein Kerem's new pediatric COVID-19 ICU. Credit: Hadassah Medical Center.
A nurse cares for a baby at Hadassah Medical Center-Ein Kerem's new pediatric COVID-19 ICU. Credit: Hadassah Medical Center.

Officials at Jerusalem’s Herzog Medical Center on Sunday closed the hospital’s coronavirus ward, the last one operating in the country.

The ward’s closure means that future COVID-19 patients will be treated in regular hospital wards.

Herzog’s coronavirus ward opened in August 2020, and treated 2,000 patients.

“We are closing the department with a sense of joy and pride. There is a feeling of real joy that the corona event, with its severe consequences, is behind us,” said Herzog director Dr. Kobi Haviv.

“We are the only hospital in Israel that worked and treated the corona patients continuously. The hospital staff was stretched to the limit during the waves of infection. For close to three years, we conducted ourselves according to the accordion method, with the transfer of medical and paramedical personnel between the departments, as needed,” he added.

There are currently some 10,750 active COVID-19 cases in Israel, of which 21 are considered serious or critical, according to Health Ministry figures.

The Health Ministry recorded 12,487 Israeli deaths from the coronavirus since an 88-year-old Holocaust survivor became the country’s first fatality on March 20, 2020.

You have read 3 articles this month.
Register to receive full access to JNS.

Just before you scroll on...

Israel is at war. JNS is combating the stream of misinformation on Israel with real, honest and factual reporting. In order to deliver this in-depth, unbiased coverage of Israel and the Jewish world, we rely on readers like you. The support you provide allows our journalists to deliver the truth, free from bias and hidden agendas. Can we count on your support? Every contribution, big or small, helps JNS.org remain a trusted source of news you can rely on.

Become a part of our mission by donating today
Topics
Comments
Thank you. You are a loyal JNS Reader.
You have read more than 10 articles this month.
Please register for full access to continue reading and post comments.